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heparin and indomethacin in the prevention of deep-vein
thrombosis after total knee arthroplasty in Asian patients.
METHODS: One hundred ﬁfty patients undergoing 
total knee arthroplasty were randomly divided into 
three groups. Group I (the control group) consisted of 51
patients receiving no prophylaxis with an anticoagulant.
Group II consisted of 50 patients receiving the low mol-
ecular weight heparin fraxiparine, and group III consisted
of 49 patients receiving indomethacin. Bilateral ascend-
ing venograms were performed preoperatively and at ﬁve
to seven days postoperatively. A third venogram was 
performed at 3 months in patients who had had a deep
vein thrombosis. RESULTS: The prevalence of deep vein
thrombosis was 71% for the control group versus 50%
for the fraxiparine group (p = 0.042), and 45% for the
indomethacin group (p = 0.011). Deep vein thromboses
were symptomatic in only 28% of the cases, and there
was no pulmonary embolism. CONCLUSIONS:
Fraxiparine and indomethacin signiﬁcantly lowered the
prevalence of deep-vein thrombosis after total knee
arthroplasty as compared with the control. Prophylaxis
for deep vein thrombosis in the Asian population ap-
peared to be warranted. Furthermore, deep-vein throm-
bosis in the calf showed a tendency to improve with 
time.
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OBJECTIVE: We have tried to know the prognostic value
of Troponin T levels (TnT) in patients (p) with a clinical
presentation suggestive of angina, which induced hospi-
tal admission. METHODS: We have followed up 241
consecutive p, 162 male and 79 female, mean age 67.4y.
(range 18 to 89) who initially did not develop a Q-wave
acute myocardial infarction. RESULTS: TnT levels were
higher than 0.1ng/ml in 90p (37%, group TnT+) and
lower than 0.1 in the 63% (group TnT-). Both groups
had comparable age and proportion of women (69 vs. 67
years and 35% vs. 32%, respectively). Every non-Q-wave
infarction p (a = 27) had high levels of TnT. Several
outcome events [death (Dh), heart failure (HF), acute
myocardial infarction (AMI) or need of revascularization
(Rev)] were recalled either by phone or personal interview
three months after the initial clinical episode. Relative
risks and 95% conﬁdence limits of TnT+ for grouped
events considering all the patients was 2.24 for Dh or HF;
2.42 for Dh or AMI; 2.52 for Dh or HF or AMI and 2.14
for Dh, HF, AMI or Rev., and excluding those with non-
Q-wave infarction was 2.66 for Dh or HF; 3.2 for Dh or
AMI; 2.8 for Dh or HF or AMI and 2.66 for Dh, HF,
AMI or Rev. CONCLUSIONS: Patients with chest pain
who require hospitalization due to an admission diagno-
sis of unstable angina or non-Q-wave myocardial infarc-
tion have a different three month outcome depending on
the troponin levels in the ﬁrst 24 hours. Levels higher
than 0.1ng/ml almost triplicate the risk of major events
even when patients with non-Q-wave infarction are
excluded.
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OBJECTIVES: To evaluate the possibility to use data
from insurance companies for assessing the quality of
drug treatment and to assess the prescribing patterns 
for essential hypertension in Slovak Republic (SR).
METHODS: From population of 5 selected counties in
Slovak Republic insured in General Sickness Fund
(509,241 people, almost 10% of population of SR),
81,870 patients were treated for essential hypertension in
2001. Antihypertensive treatment of those patients was
assessed according to the quantity and quality of pre-
scribed drugs. A set of non-speciﬁc and disease-speciﬁc
markers of rationality was developed and used for this
purpose. RESULTS: Average number of daily deﬁned
doses (DDD) for patient was 3537 times a year. The 
most common prescribed antihypertensive group were
angiotensin-converting enzyme inhibitors (126,5DDD on
patient and year). A total of 35% of patients had pre-
scribed less than 150DDDs for a year and almost 10%
had more than 450DDDs from one group of antihy-
pertensives. Great differences between counties were
observed. CONCLUSIONS: Unique characteristic of
Slovak system of issuing prescriptions that require enter-
ing the diagnosis, allows using data from prescriptions for
the quality assessment of drug treatment. The results from
our analysis show low compliance of physicians with
existing guidelines and the need for increased activities
for improving the quality of drug treatment.
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OBJECTIVES: The beneﬁts of repair over replacement
for mitral valve dysfunction are well established.
However, despite growing experience with reparative
surgery, concerns over patients with increased comor-
bidities or requiring concomitant cardiac procedures may
still lead surgeons to elect to perform a more familiar
